The increasing focus on oncology is a major factor supporting the development of companion diagnostics. Biomarker testing can help identify molecular alterations associated with targeted cancer therapies and support treatment selection for patients with specific tumor characteristics. The Companion Diagnostic Technologies Market is becoming an increasingly important component of precision...